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The chloride intracellular channel (CLIC) family of proteins are unusual in that
they can exist in either an integral membrane-channel form or a soluble form.
Here, the expression, puriﬁcation, crystallization and preliminary diffraction
analysis of CLIC2, one of the least-studied members of this family, are reported.
Human CLIC2 was crystallized in two different forms, both in the presence of
reduced glutathione and both of which diffracted to better than 1.9 A˚ resolution.
Crystal form A displayed P212121 symmetry, with unit-cell parameters a = 44.0,
b = 74.7, c = 79.8 A˚. Crystal form B displayed P21 symmetry, with unit-cell
parameters a = 36.0, b = 66.9, c = 44.1 A˚. Structure determination will shed more
light on the structure and function of this enigmatic family of proteins.
1. Introduction
The ﬁrst member of the chloride intracellular channel (CLIC) family
was identiﬁed based on intracellular chloride-channel activity and
was puriﬁed by afﬁnity for a chloride-channel inhibitor (Landry et al.,
1993). This led to the identiﬁcation of a number of homologues that
all contain a conserved region of approximately 240 residues.
Consistent with their original identiﬁcation as chloride channels, a
number of family members are able to insert into artiﬁcial
membranes in vitro and form ion channels with varying degrees of
anion selectivity. Surprisingly, CLIC-family proteins can also exist in a
soluble form and do not possess any obvious hydrophobic trans-
membrane segments, features that are reminiscent of many bacterial
pore-forming toxins (Cromer et al., 2002). Based on a very weak
sequence similarity between omega glutathione S-transferase (GST)
and the conserved region of CLIC proteins, it was hypothesized that
in their soluble form CLIC proteins adopt the canonical GST fold
(Dulhunty et al., 2001). Structure determination of both CLIC1
(Harrop et al., 2001) and CLIC4 (Littler et al., 2005; Li et al., 2006) has
conﬁrmed this hypothesis and also revealed that CLIC1 can cova-
lently bind glutathione via a conserved cysteine (Cys24; Harrop et al.,
2001) in a similar manner to omega-class GSTO1-1 (Board et al.,
2000). The structure adopted by cytosolic GSTs and soluble CLICs
comprises two domains: an N-terminal mixed / thioredoxin-like
domain and an all--helical C-terminal domain. There is good
evidence that the N-terminus can translocate across membranes
(Tonini et al., 2000), a step in channel formation that would require
some unfolding of the N-terminal domain. Consistent with this
concept, oxidation of CLIC1 favours channel formation and leads to
an alternative form of soluble CLIC1 that is dimeric, with consider-
able unfolding of the N-terminal domain and the formation of an
intramolecular disulﬁde between Cys59 and the conserved Cys24
(Littler et al., 2004).
CLIC2 is a relatively poorly studied member of the CLIC family.
The N-terminal domain of CLIC2 lacks the cysteine equivalent to
Cys59 of CLIC1, but contains another cysteine Cys33 that together
with the conserved Cys30 (equivalent to Cys24 in CLIC1) forms a
CxxC motif similar to glutaredoxin. Based on these cysteine-residue
differences, we hypothesized that CLIC2 may undergo differential
redox regulation and conformational change relative to CLIC1. To
investigate this hypothesis, we have undertaken structural studies of
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human CLIC2 and report here the production of well diffracting
crystals that have enabled the determination of the structure of
CLIC2, which will be reported elsewhere.
2. Experimental procedures and results
2.1. Cloning, expression and purification
CLIC2 was expressed with a His-tagged ubiquitin fused at the
N-terminus. Human CLIC2 was ampliﬁed from the EST clone
AI129485 and ligated between the BamHI and PstI sites of the
pQE-30 vector (Qiagen, Clifton Hills, Australia) to produce
pQECLIC2 as described previously (Board et al., 2004). The CLIC2
insert was subcloned as a SacII/HindIII fragment into pHUE
(Catanzariti et al., 2004) to create a His6-ubiquitin-CLIC2 fusion
protein. This protein was expressed in BL21(DE3) cells grown
overnight in the presence of 0.1 mM isopropyl -thiogalactoside and
processed using the methods described by Whittington et al. (1999).
The recombinant protein was puriﬁed by immobilized metal-afﬁnity
chromatography with Ni–agarose as described previously for His-
tagged GSTs (Whittington et al., 1999). Following dialysis to remove
imidazole, the His6-ubiquitin tag was cleaved by digestion with a
ubiquitin-speciﬁc protease (Baker et al., 1994; Catanzariti et al., 2004)
and both the protease and His6-ubiquitin tag were removed by
immobilized metal-afﬁnity chromatography with Ni–agarose
(Catanzariti et al., 2004). The protein was further puriﬁed by gel
ﬁltration on a Pharmacia fast protein liquid-chromatography
Superose 12 column equilibrated with 50 mM HEPES, 10% glycerol
pH 7.0.
The puriﬁed protein was dialysed into 50 mM HEPES pH 7.5 and
100 mM NaCl and concentrated to 7.25 mg ml1 for crystal form A
and to 15 mg ml1 in 20 mM Tris–HCl pH 7.5, 50 mMNaCl for crystal
form B. The puriﬁed protein was essentially completely monomeric in
solution, as indicated by gel-ﬁltration chromatography on a Superdex
75 10/300 chromatography column (GE Biosciences) in 50 mM
sodium phosphate pH 7.4 and 100 mM sodium chloride (data not
shown), and was greater than 95% pure as determined by SDS–
PAGE.
2.2. Crystallization
All crystallization experiments were carried out using the hanging-
drop vapour-diffusion technique using 24-well Linbro tissue-culture
plates (ICN Inc.) at 292 K. Drops were formed by mixing equal
volumes (1 ml) of protein solution and reservoir solution. Two
different crystal forms were found (Fig. 1) using different batches of
puriﬁed protein at different concentrations and with slightly different
reservoir solutions. For crystal form A, the protein concentration was
7.25 mg ml1 and the reservoir solution contained 35–50%(v/v) PEG
400, 100 mM Tris–HCl pH 8.0–9.2 and 5 mM reduced glutathione
(GSH). Crystals appeared after 2–3 d. For crystal form B, the protein
concentration was 15 mg ml1 and the reservoir solution contained
30–32%(v/v) PEG 400, 100 mM Tris–HCl pH 7.5 and 5 mM GSH.
Crystals appeared after 3 d and were used immediately for X-ray data
collection. GSH was found to be a necessary ingredient for both
crystal forms.
2.3. Data collection
Both crystal forms were frozen in the buffer from the crystal-
lization drop, as the concentration of PEG 400 was sufﬁcient to
prevent ice-crystal formation. Crystals were mounted in cryo-loops
(Hampton Research, CA, USA) and transferred directly into a
stream of nitrogen gas maintained at 100 K. For crystal form A, X-ray
diffraction data were collected on BioCARS beamline 14-ID-B at the
Advanced Photon Source, Chicago, USA (Table 1). For crystal form
B, X-ray diffraction data were collected in-house using a Rigaku
RU200H generator equipped with mirror optics (Xenocs) and a
MAR Research 345 mm imaging-plate detector. Diffraction data
were integrated and scaled using HKL (Otwinowski & Minor, 1997)
for crystal form A and MOSFLM (Collaborative Computational
Project, Number 4, 1994) and SCALA (Collaborative Computational
Project, Number 4, 1994) for crystal form B. Data statistics are shown
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Figure 1
Crystals of CLIC2 in (a) crystal form A and (b) crystal form B.
Table 1
Crystal data and X-ray diffraction data-collection statistics.
Values in parentheses are for the highest resolution bin.
Crystal Form A Form B
Space group P212121 P21
Unit-cell parameters (A˚, ) a = 44.0, b = 74.7,
c = 79.8
a = 36.0, b = 66.9,
c = 44.1,  = 99.9
Resolution (A˚) 1.85 (1.92–1.85) 1.86 (1.95–1.86)
No. of crystals 1 1
Oscillation range () 360 (360  1 images) 300 (300  1 images)
Temperature (K) 100 100
Wavelength (A˚) 1.0875 1.54182
No. of observations 732050 102405
No. of unique reﬂections 23144 16303
Multiplicity 10.5 (4.9) 6.0 (5.3)
Data completeness (%) 93.9 (62.0) 99.5 (84.3)
I/(I) 31.3 (2.8) 24.2 (5.1)
Rmerge† (%) 6.8 (30.6) 4.7 (31.5)
† Rmerge =
P
hkl
P
i jIi  hIij=jhIij, where Ii is the intensity of the ith measurement of an
equivalent reﬂection with indices hkl.
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in Table 1. Both crystal forms diffracted to better than 1.9 A˚ reso-
lution. Crystal form A displayed P212121 symmetry, with unit-cell
parameters a = 44.0, b= 74.7, c= 79.8 A˚. Crystal form B displayed P21
symmetry, with unit-cell parameters a = 36.0, b = 66.9, c = 44.1 A˚,
 = 99.9.
The structures of CLIC2 in both crystal forms have now been
determined by molecular replacement using the published CLIC1
structure (Harrop et al., 2001) as a probe and have been reported
elsewhere (Cromer et al., 2007). The atomic coordinates and structure
factors (PDB codes 2r4v and 2r5g for crystal forms A and B,
respectively) have been deposited in the Protein Data Bank at the
Research Collaboratory for Structural Bioinformatics, Rutgers
University, New Brunswick, NJ, USA (http://www.rcsb.org). These
structures will provide further insight into the structure and function
of this intriguing family of proteins.
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